Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Clinical trial NCT00220805 · COMPLETED

Trial details

NCT number: NCT00220805
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2004-01-01
Primary completion: 2005-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.